We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

16 hedge funds and large institutions have $3.84M invested in Catheter Precision in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 1

167% more funds holding

Funds holding: 6 → 16 (+10)

28% more capital invested

Capital invested by funds: $3M → $3.84M (+$846K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
16
Holders Change
+10
Holders Change %
+166.67%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$784K
2
DY
Dowling & Yahnke
California
+$458K
3
GCP
GSA Capital Partners
United Kingdom
+$327K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$261K
5
BCM
Bridgeway Capital Management
Texas
+$196K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$116K
2
UBS Group
UBS Group
Switzerland
-$3K
3
TSW
Thompson Siegel & Walmsley
Virginia
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
1
Royce & Associates
New York
$1.48M +$784K +12 +57%
Renaissance Technologies
2
Renaissance Technologies
New York
$725K +$65.4K +1 +7%
DY
3
Dowling & Yahnke
California
$319K +$458K +7 New
GCP
4
GSA Capital Partners
United Kingdom
$231K +$327K +5 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$180K +$261K +4 New
BCM
6
Bridgeway Capital Management
Texas
$154K +$196K +3 New
VF
7
Virtu Financial
New York
$137K +$196K +3 New
EGM
8
Engineers Gate Manager
New York
$96K +$131K +2 New
Bank of New York Mellon
9
Bank of New York Mellon
New York
$89K +$131K +2 New
Squarepoint
10
Squarepoint
New York
$80K – – –
Morgan Stanley
11
Morgan Stanley
New York
$71K +$131K +2 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$69K +$131K +2 New
Citadel Advisors
13
Citadel Advisors
Florida
$59K – – –
ACM
14
Alethea Capital Management
Washington
$57K – – –
Jane Street
15
Jane Street
New York
$52K +$65.4K +1 New
Bank of America
16
Bank of America
North Carolina
$41K +$65.4K +1 New
Osaic Holdings
17
Osaic Holdings
Arizona
$3K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$1K – – –
Two Sigma Advisers
19
Two Sigma Advisers
New York
– -$116K -2 Closed
TSW
20
Thompson Siegel & Walmsley
Virginia
– -$2K – –
UBS Group
21
UBS Group
Switzerland
– -$3K – –

VTAK Hedge Fund Activity: Q1 2021 in Review

16 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2021, worth a combined $3.84M — up 28% from $3M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new VTAK positions and 1 closed out — a net gain of 10 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Royce & Associates, adding an estimated $784K. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $116K sold.

  • 16 institutional investors held Catheter Precision (VTAK) as of Q1 2021, up from 6 in Q4 2020.
  • Funds reported $3.84M of Catheter Precision stock for Q1 2021, up 28% quarter-over-quarter.
  • 11 funds opened new Catheter Precision positions in Q1 2021 and 1 closed out, a net change of +10 holders.
  • The largest Catheter Precision buyer in Q1 2021 was Royce & Associates, an estimated $784K added.
  • The largest Catheter Precision seller in Q1 2021 was Two Sigma Advisers, an estimated $116K sold.

Based on aggregated 13F filings for Q1 2021.